We have recently reported how female DLBCL patients manifested significant alterations in plasma levels of phosphatidylinositols (PIs), which could be explained by the depletion of plasma depots of PI34:1 to produce second messengers of the PI3K pathway [274]. This evidence concerns the gene PIK3CA and diffuse large B-cell lymphoma.